GIIANT PHARMA
Giiant is a preclinical-stage biotech company that, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.
GIIANT PHARMA
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2014-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.giiant.com
Total Employee:
1+
Status:
Active
Contact:
(514) 825-9035
Email Addresses:
[email protected]
Total Funding:
15 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Enthera
Enthera is a biotech company whose mission is to find new therapeutic approaches to treat diabetes and gastrointestinal complication.
Oxeia Biopharmaceuticals
Oxeia Biopharmaceuticals is a clinical stage biotech company.
Priority Health
Priority Health is an award-winning health benefits company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Seed Round - Giiant Pharma
AQC Capital
AQC Capital investment in Seed Round - Giiant Pharma
Theodorus III
Theodorus III investment in Seed Round - Giiant Pharma
Genesys Capital
Genesys Capital investment in Seed Round - Giiant Pharma
CQDM
CQDM investment in Seed Round - Giiant Pharma
Amplitude Venture Capital
Amplitude Venture Capital investment in Seed Round - Giiant Pharma
Anges Quebec
Anges Quebec investment in Seed Round - Giiant Pharma
Amorchem
Amorchem investment in Seed Round - Giiant Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-09 | Giiant Pharma Appoints Christophe Mellon, PhD as Vice President, Discovery & Chemistry |
Official Site Inspections
http://www.giiant.com Semrush global rank: 6.12 M Semrush visits lastest month: 1.33 K
- Host name: 47.119.180.107.host.secureserver.net
- IP address: 107.180.119.47
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Giiant Pharma"
about us - Giiant Pharma – The gut-restricted IBD solution
Founded in 2010, Crystal Pharmatech is a technology-driven contract research organization, providing comprehensive solutions in solid-state research, crystallization development, pre …See details»
Giiant Pharma - Company Profile - Tracxn
Nov 27, 2024 Giiant Pharma - Developer of colon-specific anti-inflammatory therapy for ulcerative colitis. Raised a total funding of $12.2M over 2 rounds from 8 investors. Founded by …See details»
home - Giiant Pharma – The gut-restricted IBD solution
Sep 8, 2021 giiant pharma develops gut-restricted, small molecule, tissue-specific drug therapeutics for the treatment of inflammatory bowel diseases (IBD). Precision delivery …See details»
Giiant Pharma - Overview, News & Similar companies - ZoomInfo
Jan 10, 2023 Who is Giiant Pharma. Giiant is a preclinical-stage biotech company that designs gut-restricted, tissue-specific, small molecule, drug therapeutics using its proprietary Precision …See details»
Giiant Pharma Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Giiant Pharma Inc. of Montréal, QC. Get the latest business insights from Dun & Bradstreet.See details»
giiant pharma - Amorchem
Toward safer IBD therapies Giiant Pharma Inc. (www.giiant.com) is a Montreal-based preclinical-stage biotech company developing gut-restricted, small molecule, tissue-specific drug …See details»
giiant pharma inc. | LinkedIn
Giiant pharma inc. | 703 followers on LinkedIn. Towards GI Precision Delivery | Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, …See details»
Giiant Pharma - Products, Competitors, Financials, Employees ...
Giiant Pharma is a preclinical-stage biotech company focused on developing gut-restricted, small molecule drug therapeutics for the treatment of inflammatory bowel diseases (IBD). Use the …See details»
Giiant Pharma — building the next precision GI medicine company
May 26, 2021 Last week, Giiant Pharma announced the close of a US $11M (CAD $13.5M) seed round. We’re excited to co-lead this financing with Genesys Capital to build a precision GI …See details»
Giiant Pharma - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Giiant Pharma - Funding, Financials, Valuation & Investors
Giiant Pharma is a preclinical-stage biotech company.See details»
Giiant Pharma | CipherBio
Explore Giiant Pharma's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Giiant Pharma Receives Financial Support From the US Crohn’s …
Feb 24, 2023 MONTREAL–(BUSINESS WIRE)–Giiant Pharma Inc., a Canadian, preclinical-stage biotech company, today announced that the Company will receive financial support from …See details»
Giiant Pharma Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Giiant Pharma Inc. of Notre-Dame-De-L'Île-Perrot, QC. Get the latest business insights from Dun & Bradstreet.See details»
CQDM invests $500,000 in Giiant Pharma, a Quebec-based …
Montreal - June 30th 2021 - CQDM is proud to invest in Giiant Pharma’s seed financing round, joining co-leads Amplitude Ventures and Genesys Capital, alongSee details»
Giiant Pharma Inc Strengthens its Board of Directors with the ...
Jun 17, 2021 Contacts. Maxime Ranger, PhD MBA CEO, Giiant Pharma Inc E : [email protected] T: +1.514.825.9035 Véronique Bérubé, LLB Head, Operations & …See details»
Giiant Pharma Inc. extended its Seed round with AQC Capital and …
Jun 30, 2021 MONTREAL–(BUSINESSWIRE)– Giiant Pharma Inc. announced today that is closed an additional financing of $750,000 from AQC Capital (AQC) and $500,000 from …See details»
Guidant Global - Org Chart, Teams, Culture & Jobs - The Org
View Guidant Global's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Glean's org chart: understand your company resources better
Great work requires great collaboration. Unfortunately, your organization might scale faster than you can keep up with. Although a growing headcount should mean bigger and better …See details»
Kaiser's Risant Health to become $35B system in 5 years: 14 things …
1 day ago Kaiser Permanente's Risant Health, a value-based care platform, aims to become a $35 billion organization in 5 years and acquire three to four more systems.See details»